zero0a wrote:
歐盟疫苗護照將正式啟動！
全世界跟不上台灣，所以決定卡台灣
TonyHoung2013 wrote:
我講的二期人數是國際的標準
標準？ 我告訴你做越多越安全
莫德納二期做了超過8000人，三期做了超過四萬人
巴斯得國際疫苗大廠在第二期成功了，在第三期失敗了
在第二期還沒解盲就下500萬劑訂單就是個世紀大笑話
如樓主所說，千萬不要讓炒股的有機會出脫股票
zero0a wrote:
好吧!先送美國爸爸認(恕刪)
沒三期怎麼送美國？
AZ 三期數據不明確，美國硬卡不給過。
怎麼做三期？
找印度？找南非？找巴西？找法國？
資金那裡來？還沒作就破產了。
The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease and hospitalisation.
This interim safety and efficacy analysis was based on 32,449 participants accruing 141 symptomatic cases of COVID-19. The trial had a 2:1 randomisation of vaccine to placebo.
Vaccine efficacy was consistent across ethnicity and age. Notably, in participants aged 65 years and over, vaccine efficacy was 80%.
內文搜尋
從 APP 打開
X